-
Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer's disease assessment across primary and specialty care
Industry News -
FDA Clearance of C2N Diagnostics' PrecivityAD2 Blood Test Advances Precision Medicine for Alzheimer's, Building on Groundwork Laid by Early ADDF Investment
Industry News -
Old drug, new tricks: prostate drug could be useful in Alzheimer’s disease
Industry News -
Dementia-related Psychosis Market Gearing Up for Outstanding Expansion at a CAGR of 26.2% During the Forecast Period (2026-2036) | DelveInsight
Industry News -
New WHO guidelines: up to 45% of dementia risk could be prevented or delayed
Industry News -
Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at AAIC
Industry News -
Dementia Treatment and Prevention: Simple changes make a big difference
Industry News
